These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 18680776)

  • 1. Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens.
    Debba-Pavard M; Ait-Lounis A; Soubieux D; Rasschaert D; Dambrine G
    Vaccine; 2008 Sep; 26(38):4904-12. PubMed ID: 18680776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
    Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
    Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek's disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription.
    Quéré P; Rivas C; Ester K; Novak R; Ragland WL
    Arch Virol; 2005 Mar; 150(3):507-19. PubMed ID: 15592893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine-induced host responses against very virulent Marek's disease virus infection in the lungs of chickens.
    Haq K; Abdul-Careem MF; Shanmuganthan S; Thanthrige-Don N; Read LR; Sharif S
    Vaccine; 2010 Aug; 28(34):5565-72. PubMed ID: 20600510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time.
    Fakhrul Islam AF; Walkden-Brown SW; Groves PJ; Underwood GJ
    Avian Pathol; 2008 Jun; 37(3):225-35. PubMed ID: 18568648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model.
    Baigent SJ; Smith LP; Currie RJ; Nair VK
    Avian Pathol; 2007 Dec; 36(6):467-74. PubMed ID: 17994325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Marek's disease virus load in peripheral blood lymphocytes at various stages of infection and clinical Marek's disease in broiler chickens.
    Islam AF; Walkden-Brown SW; Islam A; Underwood GJ; Groves PJ
    Avian Pathol; 2006 Feb; 35(1):42-8. PubMed ID: 16448942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C; Nervi P; Risso M
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular evaluation of responses to vaccination and challenge by Marek's disease viruses.
    Tan J; Cooke J; Clarke N; Tannock GA
    Avian Pathol; 2007 Oct; 36(5):351-9. PubMed ID: 17899458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
    Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
    Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
    Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
    Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
    Zhang Y; Sharma JM
    Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination-challenge interval markedly influences protection provided by Rispens CVI988 vaccine against very virulent Marek's disease virus challenge.
    Islam T; Walkden Brown SW; Renz KG; Fakhrul Islam AF; Ralapanawe S
    Avian Pathol; 2013 Dec; 42(6):516-26. PubMed ID: 24098951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral kinetics, shedding profile, and transmission of serotype 1 Marek's disease vaccine Rispens/CVI988 in maternal antibody-free chickens.
    Islam T; Renz KG; Walkden-Brown SW; Ralapanawe S
    Avian Dis; 2013 Jun; 57(2 Suppl):454-63. PubMed ID: 23901761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine gene expression patterns associated with immunization against Marek's disease in chickens.
    Abdul-Careem MF; Hunter BD; Parvizi P; Haghighi HR; Thanthrige-Don N; Sharif S
    Vaccine; 2007 Jan; 25(3):424-32. PubMed ID: 17070626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
    Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
    Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.
    Haq K; Elawadli I; Parvizi P; Mallick AI; Behboudi S; Sharif S
    Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV.
    Lee LF; Lupiani B; Silva RF; Kung HJ; Reddy SM
    Vaccine; 2008 Mar; 26(15):1887-92. PubMed ID: 18313812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype.
    Lee LF; Bacon LD; Yoshida S; Yanagida N; Zhang HM; Witter RL
    Avian Dis; 2004; 48(1):129-37. PubMed ID: 15077806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.